Resveratrol Down-Regulates Myosin Light Chain Kinase, Induces Apoptosis and Inhibits Diethylnitrosamine-Induced Liver Tumorigenesis in Rats

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Alteration of Hepatic Proinflammatory Cytokines is Involved in the Resveratrol-Mediated Chemoprevention of Chemically-Induced Hepatocarcinogenesis

(2011) Thomas Mbimba et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Targeting integrins in hepatocellular carcinoma

(2011) Yanhua Wu et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Resveratrol Suppresses Oxidative Stress and Inflammatory Response in Diethylnitrosamine-Initiated Rat Hepatocarcinogenesis

(2010) A. Bishayee et al.   Cancer Prevention Research

Resveratrol and derivatives for the prevention and treatment of cancer

(2010) Simone Fulda   DRUG DISCOVERY TODAY

Suppression of the Inflammatory Cascade is Implicated in Resveratrol Chemoprevention of Experimental Hepatocarcinogenesis

(2010) Anupam Bishayee et al.   PHARMACEUTICAL RESEARCH

Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms

(2009) Mohammad Athar et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials

(2009) A. Bishayee   Cancer Prevention Research

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

(2008) Joydeb Kumar Kundu et al.   CANCER LETTERS

Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: Inhibition of cell proliferation and induction of apoptosis

(2008) Anupam Bishayee et al.   CHEMICO-BIOLOGICAL INTERACTIONS